Charles River Announces Promotion of Dr. Christophe Berthoux as Major Step in Realignment of Its Global Sales and Marketing OrganizationIndustry leader strengthens interface with customers worldwide
WILMINGTON, Mass., September 29, 2008--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today the promotion of Dr. Christophe Berthoux to the newly-created position of Executive Vice President, Global Sales and Marketing and Chief Commercial Officer. In this role, Dr. Berthoux will lead the global realignment of the Company's Sales and Marketing organization, the goal of which is to further enhance the Company's interface with its customers.
"Given Dr. Berthoux's scientific and business training, his in-depth customer knowledge, as well as his considerable sales and marketing experience, I am confident that he will provide extraordinary levels of leadership in driving this newly created global organization," said James C. Foster, Chairman, President and Chief Executive Officer of Charles River.
Mr. Foster continued, "Our global Sales and Marketing organization will enhance the Company's ability to provide customers with a centralized, integrated approach to their drug development programs across all business segments. As our customers continue to transform their business models, we must evolve with them. We view a global Sales and Marketing organization as a milestone in the quest to truly become one with our customers."
About Charles River
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development efforts. Our more than 9,000 employees worldwide are focused on providing clients with exactly what they need to improve and expedite the discovery, development through first-in-human evaluation, and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
CONTACT: Charles River Media Contact:Amy Cianciaruso, firstname.lastname@example.org
orInvestor Contact:Susan E. Hardy, email@example.com
Source: Charles River Laboratories International, Inc.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
The Charles River Animal Welfare department has made recent strides in further integrating the 3Rs into our operations. Charles River representatives are acting as ambassadors within the industry to elevate the importance of animal welfare in laboratory animal research
Through this agreement, Charles River will sell the Axcess™ System, an offering that combines the Bruker MALDI Biotyper system with a custom data analysis software solution that allows instantaneous access to the Accugenix® microbial database for identifications.
Jun 22–Jun 26
Founded in 1960, the Teratology Society is a multidisciplinary society drawing its members from academia, industry and government. In addition to being an exhibitor, Charles River is pleased to be a platinum level sponsor and to be participating in this year’s meeting with multiple posters presentations.
May 20–May 22
Please visit Charles River tabletop #611 to discuss our full portfolio of products and services, including our Preclinical Services, as well as our Biopharmaceutical Services, which deliver client-focused solutions for the specific testing and manufacturing requirements of your biologic.
May 23–May 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
Charles River Laboratories, Inc.